Riskpilot← Back to searchSign inGet full accessNORKLINIKKEN STAVANGER AS
ASActiveOrg 926545809Lars Hertervigs Gate 6, 4005 StavangerPhysiotherapy activities · NACE 8695Est. 20210 employees
Revenue 2024
NOK 5,7M
+37% vs 2023
EBITDA margin
14.1%
+8483% vs 2023
Equity ratio
65.3%
Financial strength
Net profit 2024
NOK 643K
+542% vs 2023
| Revenue | NOK 5,7M | +37% |
| EBITDA | NOK 797K | +8483% |
| Net profit | NOK 643K | +542% |
| Total assets | NOK 1,2M | +54% |
| Equity | NOK 812K | +379% |
| Employees | 0 | — |
Legal name
NORKLINIKKEN STAVANGER AS
Org number
926545809
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
8. februar 2021
Share capital
NOK 829 980
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Drive med drift av kiropraktor- og fysioterapiklinikk og alt som er naturlig forbundet, herunder å yte tjenester, selge produkter, drive treningssenter og lignende.
Address
Lars Hertervigs Gate 6, 4005 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 885 | 2 614 | 4 136 | 5 650 |
| Staff expenses | −12 | −45 | −6 | −24 |
| EBITDA | −171 | −59 | 9 | 797 |
| Depreciation & amort. | −120 | −123 | −138 | −123 |
| EBIT | −292 | −182 | −128 | 673 |
| Net financials | −20 | −21 | −17 | −13 |
| Profit before tax | −311 | −203 | −145 | 661 |
| Tax | −0 | −0 | −0 | 18 |
| Net profit | −311 | −203 | −145 | 643 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 751 | 739 | 807 | 1 245 |
| Equity | 219 | 15 | 170 | 812 |
| Long-term debt | 153 | 64 | 0 | 0 |
| Short-term debt | 379 | 660 | 637 | 432 |
| Total debt | 532 | 723 | 637 | 432 |
EBITDA margin
14.1%
This company
15.8%
Market median
-11% vs market
20212024
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
20212024
Return on equity
79.1%
This company
18.4%
Market median
+330% vs market
20212024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20212024
Asset turnover
4.54×
This company
1.12×
Market median
+305% vs market
20212024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TK Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
CF Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (3) | ||
| Board of Directors | 2021 – 2023 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 35% | 35% | 2024 | |
| Company | 35% | 35% | 2024 | |
| Company | 15% | 15% | 2024 | |
| Company | 10% | 10% | 2024 | |
| Individual | 5% | 5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sh Helse As
NORKLINIKKEN STAVANGER AS Board members of NORKLINIKKEN STAVANGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Kopreitan | Chief Executive Officer | 0 companies |
| Christer Fardan Olsnes | Chief Executive Officer | 0 companies |
| Eirik Larsen | Board of Directors | 0 companies |
| Anne Schøyen Hammond | Board of Directors | 0 companies |
| Daniel Bjelland Dyrstad | Board of Directors | 0 companies |
| Mikal Dyrstad | Chairman | 0 companies |
| Anders Bernt Knudsen | Chairman | 0 companies |
| Henrik Wietfeldt | Board of Directors | 0 companies |